Cohance Lifesciences Ltd (COHANCE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003386,
    "name": "Cohance Life",
    "stock_name": "Cohance Life",
    "full_name": "Cohance Lifesciences Ltd",
    "name_url": "stocks-analysis/cohance-life",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "454.05",
    "chg": -7.5,
    "chgp": "-1.62%",
    "dir": -1,
    "prev_price": "461.55",
    "mcapval": "17,542.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543064,
    "symbol": "COHANCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE03QK01018",
    "curr_date": "Sep 24, 03:30 PM",
    "curr_time": "20:51 PM",
    "last_traded_at": "Sep 24, 03:30 PM IST",
    "bse_nse_vol": "3.85 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cohance-life-1003386-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Cohance Lifesciences Ltd Upgraded to Sell on Technical Improvements Despite Weak Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-financials-4200717",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CohanceLifescie_mojoScore_4200717.png",
        "date": "2026-09-22 09:00:20",
        "description": "Cohance Lifesciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 21 September 2026, driven primarily by a shift in technical indicators despite ongoing financial challenges. The pharmaceutical and biotechnology company’s Mojo Score improved to 40.0, reflecting a mildly bullish technical outlook, though fundamental and valuation concerns persist amid deteriorating financial trends."
      },
      {
        "title": "Cohance Lifesciences Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-4200437",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CohanceLifescie_technicaldot_4200437.png",
        "date": "2026-09-22 08:07:26",
        "description": "Cohance Lifesciences Ltd has experienced a notable shift in its technical parameters, moving from a mildly bearish to a mildly bullish trend on the weekly charts. Despite this positive momentum, the stock continues to face headwinds on longer-term monthly indicators, reflecting a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Cohance Lifesciences Ltd Surges 7.0% to Day's High of Rs 468.7 — Outperforms Sector by 5.4 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-hits-intraday-high-with-701-surge-on-21-sep-2026-4200031",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CohanceLifescie_priceRelatedfactors_4200031.png",
        "date": "2026-09-21 13:32:02",
        "description": "The Sensex climbed 0.79% on 21 Sep 2026, yet Cohance Lifesciences Ltd outpaced both the benchmark and its sector with a robust 7.0% gain, reaching an intraday high of Rs 468.7. That 5.4-percentage-point outperformance signals a distinctly stock-specific surge rather than a market-wide lift."
      },
      {
        "title": "Cohance Lifesciences Ltd Faces Technical Momentum Shift Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-faces-technical-momentum-shift-amid-bearish-signals-4199162",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CohanceLifescie_technicaldot_4199162.png",
        "date": "2026-09-21 08:04:01",
        "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish outlook. Despite some mildly bullish daily moving averages, key indicators such as MACD, Bollinger Bands, and KST on weekly and monthly charts suggest growing bearish pressures, reflecting the stock’s challenging performance relative to broader market benchmarks."
      },
      {
        "title": "Cohance Lifesciences Ltd Technical Momentum Shifts Amid Bearish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-technical-momentum-shifts-amid-bearish-outlook-4196794",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CohanceLifescie_technicaldot_4196794.png",
        "date": "2026-09-18 08:04:30",
        "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a modest daily gain of 1.64%, the company’s overall technical indicators and fundamental scores suggest a challenging outlook, with the MarketsMOJO Mojo Grade recently downgraded from Sell to Strong Sell."
      },
      {
        "title": "Cohance Lifesciences Ltd Faces Technical Momentum Shift Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-faces-technical-momentum-shift-amid-bearish-signals-4194287",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CohanceLifescie_technicaldot_4194287.png",
        "date": "2026-09-16 08:09:18",
        "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish stance. Despite some mildly bullish daily moving averages, the broader technical indicators suggest caution for investors as the stock continues to underperform the benchmark Sensex and faces deteriorating momentum across weekly and monthly charts."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-4193161",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CohanceLifescie_mojoScore_4193161.png",
        "date": "2026-09-15 10:11:10",
        "description": "Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 September 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Cohance Lifesciences Ltd Technical Momentum Shifts Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-technical-momentum-shifts-amid-prolonged-downtrend-4188622",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CohanceLifescie_technicaldot_4188622.png",
        "date": "2026-09-10 08:04:40",
        "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite some positive signals on shorter timeframes, the broader monthly indicators remain bearish, reflecting ongoing challenges for the stock amid a difficult market environment."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-4182525",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CohanceLifescie_mojoScore_4182525.png",
        "date": "2026-09-04 10:10:05",
        "description": "Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 597,
    "sid": "1003386",
    "stock_news_url": "https://www.marketsmojo.com/news/cohance-lifesciences-1003386"
  },
  "announcements": [
    {
      "caption": "General Upadte",
      "datetime": "21-Sep-2026",
      "details": "General update",
      "source": "BSE"
    },
    {
      "caption": "General Update",
      "datetime": "18-Sep-2026",
      "details": "General update",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "17-Sep-2026",
      "details": "Proceedings of Annual General Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has declared <strong>100%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 25 Sep 20",
          "dt": "2020-09-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Cohance Lifesciences Ltd Upgraded to Sell on Technical Improvements Despite Weak Financials

2026-09-22 09:00:20

Cohance Lifesciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 21 September 2026, driven primarily by a shift in technical indicators despite ongoing financial challenges. The pharmaceutical and biotechnology company’s Mojo Score improved to 40.0, reflecting a mildly bullish technical outlook, though fundamental and valuation concerns persist amid deteriorating financial trends.

Read full news article

Cohance Lifesciences Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-09-22 08:07:26

Cohance Lifesciences Ltd has experienced a notable shift in its technical parameters, moving from a mildly bearish to a mildly bullish trend on the weekly charts. Despite this positive momentum, the stock continues to face headwinds on longer-term monthly indicators, reflecting a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Cohance Lifesciences Ltd Surges 7.0% to Day's High of Rs 468.7 — Outperforms Sector by 5.4 Percentage Points

2026-09-21 13:32:02

The Sensex climbed 0.79% on 21 Sep 2026, yet Cohance Lifesciences Ltd outpaced both the benchmark and its sector with a robust 7.0% gain, reaching an intraday high of Rs 468.7. That 5.4-percentage-point outperformance signals a distinctly stock-specific surge rather than a market-wide lift.

Read full news article

Cohance Lifesciences Ltd Faces Technical Momentum Shift Amid Bearish Signals

2026-09-21 08:04:01

Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish outlook. Despite some mildly bullish daily moving averages, key indicators such as MACD, Bollinger Bands, and KST on weekly and monthly charts suggest growing bearish pressures, reflecting the stock’s challenging performance relative to broader market benchmarks.

Read full news article

Cohance Lifesciences Ltd Technical Momentum Shifts Amid Bearish Outlook

2026-09-18 08:04:30

Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a modest daily gain of 1.64%, the company’s overall technical indicators and fundamental scores suggest a challenging outlook, with the MarketsMOJO Mojo Grade recently downgraded from Sell to Strong Sell.

Read full news article

Cohance Lifesciences Ltd Faces Technical Momentum Shift Amid Bearish Signals

2026-09-16 08:09:18

Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish stance. Despite some mildly bullish daily moving averages, the broader technical indicators suggest caution for investors as the stock continues to underperform the benchmark Sensex and faces deteriorating momentum across weekly and monthly charts.

Read full news article

Cohance Lifesciences Ltd is Rated Sell

2026-09-15 10:11:10

Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Cohance Lifesciences Ltd Technical Momentum Shifts Amid Prolonged Downtrend

2026-09-10 08:04:40

Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite some positive signals on shorter timeframes, the broader monthly indicators remain bearish, reflecting ongoing challenges for the stock amid a difficult market environment.

Read full news article

Cohance Lifesciences Ltd is Rated Sell

2026-09-04 10:10:05

Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

View All News